Global Phage Therapy Market Research Report 2023(Status and Outlook)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,800	149 Pages	Bosson Research	May, 2023	BOSS18175065

Best Price Guarantee
Price	from $2,800
Length	149 Pages
Publisher	Bosson Research
Published Date	May, 2023
SKU	BOSS18175065

Global Phage Therapy Market Research Report 2023(Status and Outlook)

Report Overview

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

The Global Phage Therapy Market Size was estimated at USD 32.00 million in 2022 and is projected to reach USD 99.54 million by 2029, exhibiting a CAGR of 17.60% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Phage Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Phage Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Phage Therapy market in any manner.

Global Phage Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

NPO Microgen

Proteon Pharmaceuticals

Phagelux

Intralytix

Micreos

Eliava BioPreparations

Locus Biosciences,Inc

Pharmex Group,LLC

Pherecydes Pharma

APS Biocontrol Ltd. (APS)

Qingdao Phagepharm Bio-tech

Fixed-Phage Limited

Zeptometrix

Phage International, Inc.

MicroMir

iNtODEWORLD, Inc.

NEXTBIOTICS

Armata Pharmaceuticals, Inc.

Innophage

Adaptive Phage Therapeutics

TechnoPhage

Market Segmentation (by Type)

DsDNA Bacteriophage

SsDNA Bacteriophage

SsRNA Bacteriophage

Others

Market Segmentation (by Application)

Construction

Aerospace

Agriculture

Automotive

Industrial Manufacturing

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Phage Therapy Market

Overview of the regional outlook of the Phage Therapy Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

1 Research Methodology and Statistical Scope: 1.1 Market Definition and Statistical Scope of Phage Therapy; 1.2 Key Market Segments; 1.2.1 Phage Therapy Segment by Type; 1.2.2 Phage Therapy Segment by Application; 1.3 Methodology & Sources of Information; 1.3.1 Research Methodology; 1.3.2 Research Process; 1.3.3 Market Breakdown and Data Triangulation; 1.3.4 Base Year; 1.3.5 Report Assumptions & Caveats
2 Phage Therapy Market Overview: 2.1 Global Market Overview; 2.1.1 Global Phage Therapy Market Size (M USD) Estimates and Forecasts (2018-2029); 2.1.2 Global Phage Therapy Sales Estimates and Forecasts (2018-2029); 2.2 Market Segment Executive Summary; 2.3 Global Market Size by Region
3 Phage Therapy Market Competitive Landscape: 3.1 Global Phage Therapy Sales by Manufacturers (2018-2023); 3.2 Global Phage Therapy Revenue Market Share by Manufacturers (2018-2023); 3.3 Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3); 3.4 Global Phage Therapy Average Price by Manufacturers (2018-2023); 3.5 Manufacturers Phage Therapy Sales Sites, Area Served, Product Type; 3.6 Phage Therapy Market Competitive Situation and Trends; 3.6.1 Phage Therapy Market Concentration Rate; 3.6.2 Global 5 and 10 Largest Phage Therapy Players Market Share by Revenue; 3.6.3 Mergers & Acquisitions, Expansion
4 Phage Therapy Industry Chain Analysis: 4.1 Phage Therapy Industry Chain Analysis; 4.2 Market Overview of Key Raw Materials; 4.3 Midstream Market Analysis; 4.4 Downstream Customer Analysis
5 The Development and Dynamics of Phage Therapy Market: 5.1 Key Development Trends; 5.2 Driving Factors; 5.3 Market Challenges; 5.4 Market Restraints; 5.5 Industry News; 5.5.1 New Product Developments; 5.5.2 Mergers & Acquisitions; 5.5.3 Expansions; 5.5.4 Collaboration/Supply Contracts; 5.6 Industry Policies
6 Phage Therapy Market Segmentation by Type: 6.1 Evaluation Matrix of Segment Market Development Potential (Type); 6.2 Global Phage Therapy Sales Market Share by Type (2018-2023); 6.3 Global Phage Therapy Market Size Market Share by Type (2018-2023); 6.4 Global Phage Therapy Price by Type (2018-2023)
7 Phage Therapy Market Segmentation by Application: 7.1 Evaluation Matrix of Segment Market Development Potential (Application); 7.2 Global Phage Therapy Market Sales by Application (2018-2023); 7.3 Global Phage Therapy Market Size (M USD) by Application (2018-2023); 7.4 Global Phage Therapy Sales Growth Rate by Application (2018-2023)
8 Phage Therapy Market Segmentation by Region: 8.1 Global Phage Therapy Sales by Region; 8.1.1 Global Phage Therapy Sales by Region; 8.1.2 Global Phage Therapy Sales Market Share by Region; 8.2 North America; 8.2.1 North America Phage Therapy Sales by Country; 8.2.2 U.S.; 8.2.3 Canada; 8.2.4 Mexico; 8.3 Europe; 8.3.1 Europe Phage Therapy Sales by Country; 8.3.2 Germany; 8.3.3 France; 8.3.4 U.K.; 8.3.5 Italy; 8.3.6 Russia; 8.4 Asia Pacific; 8.4.1 Asia Pacific Phage Therapy Sales by Region; 8.4.2 China; 8.4.3 Japan; 8.4.4 South Korea; 8.4.5 India; 8.4.6 Southeast Asia; 8.5 South America; 8.5.1 South America Phage Therapy Sales by Country; 8.5.2 Brazil; 8.5.3 Argentina; 8.5.4 Columbia; 8.6 Middle East and Africa; 8.6.1 Middle East and Africa Phage Therapy Sales by Region; 8.6.2 Saudi Arabia; 8.6.3 UAE; 8.6.4 Egypt; 8.6.5 Nigeria; 8.6.6 South Africa
9 Key Companies Profile: 9.1 NPO Microgen; 9.1.1 NPO Microgen Phage Therapy Basic Information; 9.1.2 NPO Microgen Phage Therapy Product Overview; 9.1.3 NPO Microgen Phage Therapy Product Market Performance; 9.1.4 NPO Microgen Business Overview; 9.1.5 NPO Microgen Phage Therapy SWOT Analysis; 9.1.6 NPO Microgen Recent Developments; 9.2 Proteon Pharmaceuticals; 9.2.1 Proteon Pharmaceuticals Phage Therapy Basic Information; 9.2.2 Proteon Pharmaceuticals Phage Therapy Product Overview; 9.2.3 Proteon Pharmaceuticals Phage Therapy Product Market Performance; 9.2.4 Proteon Pharmaceuticals Business Overview; 9.2.5 Proteon Pharmaceuticals Phage Therapy SWOT Analysis; 9.2.6 Proteon Pharmaceuticals Recent Developments; 9.3 Phagelux; 9.3.1 Phagelux Phage Therapy Basic Information; 9.3.2 Phagelux Phage Therapy Product Overview; 9.3.3 Phagelux Phage Therapy Product Market Performance; 9.3.4 Phagelux Business Overview; 9.3.5 Phagelux Phage Therapy SWOT Analysis; 9.3.6 Phagelux Recent Developments; 9.4 Intralytix; 9.4.1 Intralytix Phage Therapy Basic Information; 9.4.2 Intralytix Phage Therapy Product Overview; 9.4.3 Intralytix Phage Therapy Product Market Performance; 9.4.4 Intralytix Business Overview; 9.4.5 Intralytix Phage Therapy SWOT Analysis; 9.4.6 Intralytix Recent Developments; 9.5 Micreos; 9.5.1 Micreos Phage Therapy Basic Information; 9.5.2 Micreos Phage Therapy Product Overview; 9.5.3 Micreos Phage Therapy Product Market Performance; 9.5.4 Micreos Business Overview; 9.5.5 Micreos Phage Therapy SWOT Analysis; 9.5.6 Micreos Recent Developments; 9.6 Eliava BioPreparations; 9.6.1 Eliava BioPreparations Phage Therapy Basic Information; 9.6.2 Eliava BioPreparations Phage Therapy Product Overview; 9.6.3 Eliava BioPreparations Phage Therapy Product Market Performance; 9.6.4 Eliava BioPreparations Business Overview; 9.6.5 Eliava BioPreparations Recent Developments; 9.7 Locus Biosciences,Inc; 9.7.1 Locus Biosciences,Inc Phage Therapy Basic Information; 9.7.2 Locus Biosciences,Inc Phage Therapy Product Overview; 9.7.3 Locus Biosciences,Inc Phage Therapy Product Market Performance; 9.7.4 Locus Biosciences,Inc Business Overview; 9.7.5 Locus Biosciences,Inc Recent Developments; 9.8 Pharmex Group,LLC; 9.8.1 Pharmex Group,LLC Phage Therapy Basic Information; 9.8.2 Pharmex Group,LLC Phage Therapy Product Overview; 9.8.3 Pharmex Group,LLC Phage Therapy Product Market Performance; 9.8.4 Pharmex Group,LLC Business Overview; 9.8.5 Pharmex Group,LLC Recent Developments; 9.9 Pherecydes Pharma; 9.9.1 Pherecydes Pharma Phage Therapy Basic Information; 9.9.2 Pherecydes Pharma Phage Therapy Product Overview; 9.9.3 Pherecydes Pharma Phage Therapy Product Market Performance; 9.9.4 Pherecydes Pharma Business Overview; 9.9.5 Pherecydes Pharma Recent Developments; 9.10 APS Biocontrol Ltd. (APS); 9.10.1 APS Biocontrol Ltd. (APS) Phage Therapy Basic Information; 9.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Overview; 9.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Product Market Performance; 9.10.4 APS Biocontrol Ltd. (APS) Business Overview; 9.10.5 APS Biocontrol Ltd. (APS) Recent Developments; 9.11 Qingdao Phagepharm Bio-tech; 9.11.1 Qingdao Phagepharm Bio-tech Phage Therapy Basic Information; 9.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Overview; 9.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Product Market Performance; 9.11.4 Qingdao Phagepharm Bio-tech Business Overview; 9.11.5 Qingdao Phagepharm Bio-tech Recent Developments; 9.12 Fixed-Phage Limited; 9.12.1 Fixed-Phage Limited Phage Therapy Basic Information; 9.12.2 Fixed-Phage Limited Phage Therapy Product Overview; 9.12.3 Fixed-Phage Limited Phage Therapy Product Market Performance; 9.12.4 Fixed-Phage Limited Business Overview; 9.12.5 Fixed-Phage Limited Recent Developments; 9.13 Zeptometrix; 9.13.1 Zeptometrix Phage Therapy Basic Information; 9.13.2 Zeptometrix Phage Therapy Product Overview; 9.13.3 Zeptometrix Phage Therapy Product Market Performance; 9.13.4 Zeptometrix Business Overview; 9.13.5 Zeptometrix Recent Developments; 9.14 Phage International, Inc.; 9.14.1 Phage International, Inc. Phage Therapy Basic Information; 9.14.2 Phage International, Inc. Phage Therapy Product Overview; 9.14.3 Phage International, Inc. Phage Therapy Product Market Performance; 9.14.4 Phage International, Inc. Business Overview; 9.14.5 Phage International, Inc. Recent Developments; 9.15 MicroMir; 9.15.1 MicroMir Phage Therapy Basic Information; 9.15.2 MicroMir Phage Therapy Product Overview; 9.15.3 MicroMir Phage Therapy Product Market Performance; 9.15.4 MicroMir Business Overview; 9.15.5 MicroMir Recent Developments; 9.16 iNtODEWORLD, Inc.; 9.16.1 iNtODEWORLD, Inc. Phage Therapy Basic Information; 9.16.2 iNtODEWORLD, Inc. Phage Therapy Product Overview; 9.16.3 iNtODEWORLD, Inc. Phage Therapy Product Market Performance; 9.16.4 iNtODEWORLD, Inc. Business Overview; 9.16.5 iNtODEWORLD, Inc. Recent Developments; 9.17 NEXTBIOTICS; 9.17.1 NEXTBIOTICS Phage Therapy Basic Information; 9.17.2 NEXTBIOTICS Phage Therapy Product Overview; 9.17.3 NEXTBIOTICS Phage Therapy Product Market Performance; 9.17.4 NEXTBIOTICS Business Overview; 9.17.5 NEXTBIOTICS Recent Developments; 9.18 Armata Pharmaceuticals, Inc.; 9.18.1 Armata Pharmaceuticals, Inc. Phage Therapy Basic Information; 9.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Overview; 9.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Product Market Performance; 9.18.4 Armata Pharmaceuticals, Inc. Business Overview; 9.18.5 Armata Pharmaceuticals, Inc. Recent Developments; 9.19 Innophage; 9.19.1 Innophage Phage Therapy Basic Information; 9.19.2 Innophage Phage Therapy Product Overview; 9.19.3 Innophage Phage Therapy Product Market Performance; 9.19.4 Innophage Business Overview; 9.19.5 Innophage Recent Developments; 9.20 Adaptive Phage Therapeutics; 9.20.1 Adaptive Phage Therapeutics Phage Therapy Basic Information; 9.20.2 Adaptive Phage Therapeutics Phage Therapy Product Overview; 9.20.3 Adaptive Phage Therapeutics Phage Therapy Product Market Performance; 9.20.4 Adaptive Phage Therapeutics Business Overview; 9.20.5 Adaptive Phage Therapeutics Recent Developments; 9.21 TechnoPhage; 9.21.1 TechnoPhage Phage Therapy Basic Information; 9.21.2 TechnoPhage Phage Therapy Product Overview; 9.21.3 TechnoPhage Phage Therapy Product Market Performance; 9.21.4 TechnoPhage Business Overview; 9.21.5 TechnoPhage Recent Developments
10 Phage Therapy Market Forecast by Region: 10.1 Global Phage Therapy Market Size Forecast; 10.2 Global Phage Therapy Market Forecast by Region; 10.2.1 North America Market Size Forecast by Country; 10.2.2 Europe Phage Therapy Market Size Forecast by Country; 10.2.3 Asia Pacific Phage Therapy Market Size Forecast by Region; 10.2.4 South America Phage Therapy Market Size Forecast by Country; 10.2.5 Middle East and Africa Forecasted Consumption of Phage Therapy by Country
11 Forecast Market by Type and by Application (2024-2029): 11.1 Global Phage Therapy Market Forecast by Type (2024-2029); 11.1.1 Global Forecasted Sales of Phage Therapy by Type (2024-2029); 11.1.2 Global Phage Therapy Market Size Forecast by Type (2024-2029); 11.1.3 Global Forecasted Price of Phage Therapy by Type (2024-2029); 11.2 Global Phage Therapy Market Forecast by Application (2024-2029); 11.2.1 Global Phage Therapy Sales (K Units) Forecast by Application; 11.2.2 Global Phage Therapy Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings